<DOC>
	<DOC>NCT00204620</DOC>
	<brief_summary>The aims of this trial are to evaluate the efficacy of bendamustin in patients with metastatic soft tissue sarcoma who have progressed after or during an anthracycline-baesd chemotherapy and to assess the treatment of toxicity.</brief_summary>
	<brief_title>Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Bendamustine Hydrochloride</mesh_term>
	<criteria>Histologically confirmed metastatic or nonresectable soft tissue sarcoma Evidence of progression or relapse after an anthracyclinebased and/ or ifosfamidebased chemotherapy At least 1 bidimensionally measurable tumor lesion according to RECIST criteria No previous radiation therapy on the only measurable lesion Willingness to receive regular followup Life expectancy more than 3 months ECOG status &gt;= 2 Patients aged 18 years and beyond leucocytes &gt; 2500/µl, thrombocytes &gt; 75000/µl) Serum creatine &lt; 1,5 times the upper limit of normal value, GFR &gt; 60/ml Written patient informed consent Ability to give informed consent Previous or concurrent radiation of the index lesion (radiation of single lesion is allowed if not the index lesion) Insufficient liver function (bilirubin &gt; 1.5 the upper limit of normal, prolongation of PT and aPTT &gt; 1.5 the upper limit of normal; ASAT and ALAT &gt; 3 the upper limit of normal (patients with liver metastases ASAT and ALAT &gt; 5 the upper limit of normal) Active infection Prior therapy with Bendamustin hydrochloride Prior malignancies (other than adequately treated carcinoma in situ (CIS) of the cervix, bladder urothelium, basal cell carcinoma or adenoma of the colon including pTIS,pTIN), unless treated with curative intent and without evidence of disease &gt; 5 years Symptomatic cardio and/or cerebrovascular disease (NYHAScale III°) Interval since last chemotherapy &lt; 4 weeks Evidence of CNSmetastases Evidence of pregnancy or lactation Woman of childbearing potential without reliable methods of birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>